Observational studyFrontiers in immunology2025

Real-world effectiveness of vedolizumab in refractory pouchitis: a focus on biomarker changes during intravenous to subcutaneous transition (POUCHIVED study).

Leticia Gimeno-Pitarch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.